Early stage disease diagnosis still remains a challenge despite much efforts to develop novel imaging and diagnostic techniques. Nanoparticles used as molecular imaging contrast agents with multifunctionality and flexibility provide a platform for targeting the specific disease biomarkers and integration of imaging modalities. In this work, we developed a simplified method for synthesis of radiolabeled targeted super paramagnetic iron oxide nanoparticles (SPIOs). This method takes advantage of the chelator BAT that is conjugated to the PEG before the coating process begins. The effect of nanoparticle size and PEG density was investigated in a series of in vivo experiments. The 64Cu-VINP-SPIOs were used in the PET imaging of inflammation and 64Cu-CD105-SPIOs were used in imaging of 4T1 murine tumor model. In summary, we investigated the potential of the radiolabeled, targeted SPIOs in imaging atherosclerotic plaque and tumor in vivo using magnetic resonance imaging (MRI) and Positron emission tomography (PET). Our results show that dual modality SPIOs with active targeting mediated by affinity ligands can be a great tool in molecular imaging and diagnosis of early stage plaque and tumor.

Background: In PET/MRI, linear photon attenuation coefficients for attenuation correction (AC) cannot be directly derived, and cortical bone is, so far, usually not considered. This results in an underestimation of the average PET signal in PET/MRI. Recently introduced MR-AC methods predicting bone information from anatomic MRI or proton density weighted zero-time imaging may solve this problem in the future. However, there is an ongoing debate if the current error is acceptable for clinical use and/or research. Methods: We examined this feature for [18F] fluorodeoxyglucose (FDG) brain PET in 13 patients with clinical signs of dementia or movement disorders who subsequently underwent PET/CT and PET/MRI on the same day. Multiple MR-AC approaches including a CT-derived AC were applied. Results: The resulting PET data was compared to the CT-derived standard regarding the quantification error and its clinical impact. On a quantitative level, −11.9 to +2 % deviations from the CT-AC standard were found. These deviations, however, did not translate into a systematic diagnostic error. This, as overall patterns of hypometabolism (which are decisive for clinical diagnostics), remained largely unchanged. Conclusions: Despite a quantitative error by the omission of bone in MR-AC, clinical quality of brain [18F]FDG is not relevantly affected. Thus, brain [18F]FDG PET can already, even now with suboptimal MR-AC, be utilized for clinical routine purposes, even though the MR-AC warrants improvement.

Cyclooxygenase-2 (COX-2) is a prostaglandin-generating enzyme that exhibits low basal expression levels and is upregulated in the central nervous system (CNS) in response to inflammatory stimuli. COX-2 has been implicated in the microglial-mediated neuroinflammatory and neurodegenerative processes of multiple sclerosis (MS), a demyelinating autoimmune disease. To study COX-2 activity and the role it may play in demyelination, a novel PET radiotracer specific for COX-2, [11C]BRD1158, was developed and evaluated in the lysolecithin rodent model of focal demyelination with PET-MR imaging. Preliminary results of this pilot pre-clinical study confirmed our hypothesis that the properties of [11C]BRD1158 enable visualization and monitoring of COX-2 activity under pathological conditions induced by LPC. Radiotracer uptake correlated positively with disease progression at the site of LPC injection in male rats, peaking at day 7 and resolving by day 28. Treatment with an FDA-approved MS therapy, Siponimod, diminished the increase in COX-2 activity and tracer uptake at the lesion site and throughout the brain in both male and female rats. The results from the present study will inform future pre-clinical and translational work that validates the use of [11C]BRD1158 to image COX-2 activity as a marker of underlying inflammation in MS, leading to a better understanding of pathological and inflammatory processes in MS development and progression.

No description available.

No description available.

Cette thèse vise à tester l’hypothèse selon laquelle la maladie d’Alzheimer (MA), à ses différents stades, est responsable d’un dysfonctionnement synaptique. Ce dernier, conjointement avec d’autres processus pathologiques, pourrait mener à des modifications de l’excitabilité neuronale au sein de régions cérébrales spécifiques et, en conséquence, à des altérations de la connectivité fonctionnelle au sein des réseaux neuronaux auxquels contribuent ces régions cérébrales.Deux objectifs principaux ont été visés tout au long de ce projet. Le premier ambitionnait l’identification de nouveaux marqueurs électrophysiologiques du continuum de la MA. Le second aspirait à une meilleure compréhension de la relation entre les changements électrophysiologiques, les anomalies structurelles et métaboliques ainsi que les déficits cognitifs des patients souffrant d’une MA ou étant à risque de la développer. Afin de répondre à ces buts de recherche, une approche multimodale combinant l’exploration électrophysiologique via la magnétoencéphalographie (MEG), métabolique et structurelle via un appareil hybride associant la tomographie par émission de positons avec comme traceur le fluorodésoxyglucose (FDG) et l’imagerie par résonance magnétique structurelle (TEP-IRM), et enfin cognitive via un examen neuropsychologique a été mise en place pour tous les participants qu’ils soient dans le cadre d’un vieillissement normal ou pathologique.La première étude a investigué la manière dont le continuum de la MA altère la dynamique de l’activité cérébrale spontanée et comment cette dernière est reliée aux anomalies structurelles, métaboliques et cognitives associées à la MA. Les résultats ont principalement montré des altérations dans l’activation du réseau du mode par défaut chez les patients avec une MA constituant un corrélat électrophysiologique supplémentaire du dysfonctionnement synaptique de la MA.La deuxième étude a étudié la relation entre l'activité rythmique cérébrale en bande de fréquence alpha et les altérations en mémoire épisodique verbale en utilisant la tâche de rappel libre/rappel indicé-16 items. Nos résultats ont principalement mis en évidence un nouveau corrélat électrophysiologique du dysfonctionnement à court terme en mémoire épisodique qui peut accompagner le vieillissement pathologique.Enfin, notre dernière étude a visé à fournir une vue d'ensemble des changements électrophysiologiques associés au continuum de la MA. Nos résultats ont principalement montré une diminution globale de la connectivité fonctionnelle en bande de fréquence alpha chez les patients avec une MA soutenant la théorie selon laquelle l'hypoconnectivité apparait à un stade tardif de la démence. Ceci suggère la présence d'un syndrome de déconnexion sévère dans la MA.De manière générale, ce projet de recherche a permis l’identification de marqueurs électrophysiologiques supplémentaires de la MA ainsi qu’une meilleure compréhension du lien entre les modifications électrophysiologiques et le déficit cognitif, les anomalies structurelles ainsi qu’avec les changements métaboliques observés dans la MA. / Doctorat en Sciences psychologiques et de l'éducation / info:eu-repo/semantics/nonPublished

Background: In PET/MRI, linear photon attenuation coefficients for attenuation correction (AC) cannot be directly derived, and cortical bone is, so far, usually not considered. This results in an underestimation of the average PET signal in PET/MRI. Recently introduced MR-AC methods predicting bone information from anatomic MRI or proton density weighted zero-time imaging may solve this problem in the future. However, there is an ongoing debate if the current error is acceptable for clinical use and/or research. Methods: We examined this feature for [18F] fluorodeoxyglucose (FDG) brain PET in 13 patients with clinical signs of dementia or movement disorders who subsequently underwent PET/CT and PET/MRI on the same day. Multiple MR-AC approaches including a CT-derived AC were applied. Results: The resulting PET data was compared to the CT-derived standard regarding the quantification error and its clinical impact. On a quantitative level, −11.9 to +2 % deviations from the CT-AC standard were found. These deviations, however, did not translate into a systematic diagnostic error. This, as overall patterns of hypometabolism (which are decisive for clinical diagnostics), remained largely unchanged. Conclusions: Despite a quantitative error by the omission of bone in MR-AC, clinical quality of brain [18F]FDG is not relevantly affected. Thus, brain [18F]FDG PET can already, even now with suboptimal MR-AC, be utilized for clinical routine purposes, even though the MR-AC warrants improvement.

En oncologie ORL, l'imagerie multiparamétrique est utilisée par un nombre grandissant d'équipes. Parmi les bio-marqueurs, la captation normalisée du fluoro-désoxyglucose (SUV-FDG) en tomoscintigraphie par émission de positons (TEP) et la restriction de la diffusion en IRM (DWI-MRI) sont les plus utilisées.L'IRM couplée à la TEP (TEP/IRM) est une nouveauté qui permet une diminution très significative des doses d'irradiation délivrées par rapport à la TEP/TDM. Nous adressons notre première expérience concernant l'aspect en diffusion et en TEP/IRM dans la surveillance des patients après radio-chimiothérapie. A la question de l'interchangeabilité du FDG-PET et de la DWI-MRI, nous avons tenté d'identifier un lien en imagerie entre la cellularité tumorale et sa consommation glucidique. La cellularité tumorale est approchée en IRM par la mesure du coefficient apparent de diffusion (ADC) et son métabolisme glucidique est approché en TEP en utilisant le 18F-desoxyglucose (FDG) par la mesure de la valeur de fixation normalisée (SUV). Dans une série appariée de 33 patients, nous avons analysé la reproductibilité des mesures de l'ADC et de SUV. Puis nous avons évalué l'indépendance statistique de ces biomarqueurs. Nous avons ensuite voulu comparer les résultats de la TEP obtenus à partir de la TEP/TDM et de la TEP/IRM. Dans une série prospective appariée chez 32 patients explorés en FDG-TEP, nous avons évalué qualitativement les images obtenues par la fusion des images recalées en TEP/IRM et TEP/TDM. Nous avons ensuite comparé la pertinence clinique des deux techniques. Et enfin nous avons comparé les valeurs quantitatives de SUV obtenues du tissu sain et du tissu pathologique. / Multiparametric imaging interest and clinical use is rising for head and neck carcinoma (HNC). Among these modalities, FDG in PET and DWI-MRI are the most studied. PET/MRI is a new modality that allows in a single examination of combined various biologic biomarkers.After an optimization process of PET/MRI, we applied our first experience concerning the aspects of DWI-MRI and PET-MRI after radiation therapy. Thereafter we studied the correlation of SUV and ADC in HNC. In this study SUV and ADC values were independent parameters in HNSCC. Measurements of these two biomarkers were reproducible with almost perfect observer agreements for both methods. Neither SUV nor ADC values were able to predict the histologic grade, although a trend towards higher SUV and lower ADC values was observed in poorly differentiated tumours. Secondly, we we studied detection and quantification of focal uptake in head and neck tumours: 18F-FDG PET/MRI versus PET/CT in 32 consecutive HNSCC who underwent 18F-FDG PET/MRI and PET/CT. Attenuation correction sequence for PET/MRI and CT for PET/CT were used to caculate SUV. In results, PET/MRI coregistration and image fusion was feasible in all patients. There was no statistically significant difference between PET/MRI and PET/CT regarding rating scores for image quality, fusion quality, lesion conspicuity or anatomic location, number of detected lesions and number of patients with and without malignant lesions. A high correlation was observed for SUV measured on PET/MRI and PET/CT. SUV measured on PET/MRI were significantly lower than on PET/CT for malignant tumours, metastatic neck nodes, benign lesions, bone marrow, and liver (p <0.05).

In translational medicine, complementary functional and morphological imaging techniques are used extensively to observe physiological processes in vivo and to assess structural changes as a result of disease progression. The combination of magnetic resonance imaging (MRI) and positron emission tomography (PET) provides excellent soft tissue contrast from MRI with exceptional sensitivity and specificity from PET. This thesis explores the use of sequentially acquired PET and MR images to improve the quantification of small animal PET data. The primary focus was to improve image-based estimates of the arterial input function (AIF), which defines the amount of PET tracer within blood plasma over time. The AIF is required to produce physiological parameters quantifying key processes such as metabolism or perfusion from dynamic PET images. The gold standard for AIF measurement, however, requires serial blood sampling over the course of a PET scan, which is invasive in rat studies but prohibitive in mice due to small total blood volumes. To address this issue, the geometric transfer matrix (GTM) and recovery coefficient (RC) techniques were applied using anatomical MR images to enable the extraction of partial volume corrected image based AIFs from mouse PET images. A non-invasive AIF extraction method was also developed for rats, beginning with the optimization of an automated voxel selection algorithm to assist in extracting MR contrast agent signal time courses from dynamic susceptibility contrast (DSC) MRI data. This procedure was then combined with dynamic contrast enhanced (DCE) MRI to track a combined injection of Gadolinium-based contrast agent and PET tracer through the rat brain. By comparison with gold standard tracer blood sample data, it was found that normalized MRI-based AIFs could be successfully converted into PET tracer AIFs in the first pass phase when fitted with gamma variate functions. Finally, a MR image segmentation method used to provide PET attenuation correction in mice was validated using the Cambridge split magnet PET/MR scanner?s transmission scanning capabilities. This work recommends that contributions from MR hardware in the PET field of view must be accounted forto gain accurate estimates of tracer uptake and standard uptake values (SUVs). This thesis concludes that small animal MR data taken in the same imaging session can provide non-invasive methods to improve PET image quantification, giving added value to combined PET/MR studies over those conducted using PET alone.

Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.